Chief Scientific officer (CSO)

Scientist with many years of experience in drug development and drug discovery. Occupied several senior leadership positions in big Pharma and could establish vital scientific strategies. Also was directly involved in bringing important drugs to the market e.g. Leflunomide, Gliveec, Myfortic, Zoledronate, Zelmac, Everolimus, Pimecrolimus, ERL080, Exjade, Aliskiren. Passionate about solving problems and finding good drug candidates. Loves in silico ADMET approaches in order to save resources and to advance scientific progress in area.